The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...
18hon MSN
FDA to streamline approvals for generic biological drugs in latest move targeting health costs
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...
WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...
Citing a ProPublica investigation, lawmakers are calling on the FDA to conduct more drug testing and to alert hospitals and ...
By Jonathan Stempel (Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney ...
Two brothers were convicted in Fort Lauderdale federal court of buying up black-market HIV drugs and selling them to unwitting patients and pharmacies, including two in Miami Beach.
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
The ligament in your elbow that connects the bone in your upper arm to the one in your forearm is only about as strong as “a ...
If you miss the October vaccination window, there is still plenty of time to get protected before Thanksgiving. With ...
A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...
The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback